Mast cell inhibition by ketotifen reduces splanchnic inflammatory response in a portal hypertension model in rats

Experimental and Toxicologic Pathology

Volumn 60, Issue 4-5, 2008, Pages 347-355

  Sánchez Patán, Fernando ^a   Aller, Maria Angeles ^a   Cuellar, Carmen ^b   Rodero, Marta ^b   Corcuera, Maria Teresa ^c   Nava, Maria Paz ^b   Gómez, Fernando ^c   Blanco, Maria Dolores ^b   Guerrero, Sandra ^b   Anchuelo, R ^a   Muñiz, Enriqueta ^b   Alonso, Maria Jose ^c   Teijón, Jose Maria ^b   Arias, J ^a  

^a Club of Madrid   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Inflammation; Ketotifen; Mast cell; Portal hypertension; Rat

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHYMASE; KETOTIFEN; LACTATE DEHYDROGENASE; MICROSPHERE; POLYGLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ASSAY; INFLAMMATION; MALE; MAST CELL; MESENTERY LYMPH NODE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PROPHYLAXIS; RAT; SPLANCHNIC BLOOD FLOW; VEIN LIGATION;

ANIMALS; ANTI-ALLERGIC AGENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYPERTENSION, PORTAL; INFLAMMATION; INTESTINAL MUCOSA; KETOTIFEN; LYMPH NODES; MALE; MAST CELLS; MESENTERIC VEINS; MESENTERY; RATS; RATS, WISTAR; SERINE ENDOPEPTIDASES;

RATTUS; RATTUS NORVEGICUS;

EID: 46649110525     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2008.03.008     Document Type: Article

References (56)

1. Aller M.A., and Arias J. Portal systemic collateral development: is it a trophic adaptation mechanism to hepatic deprivation?. J Gastroenterol Hepatol 21 (2006) 1643-1645
2. Aller M.A., Arias J.L., Lorente L., Nava M.P., Durán H.J., and Arias J. Neuro-immune-endocrine functional system and vascular pathology. Med Hypotheses 57 (2001) 561-569
3. Aller M.A., Arias J.L., and Arias J. The mast cell integrates the splanchnic and systemic inflammatory response in portal hypertension. J Transl Med 5 (2007) 44
4. Aller M.A., Arias J.L., Cruz A., and Arias J. Inflammation: a way to understanding the evolution of portal hypertension. Theor Biol Med Model 4 (2007) 44
5. Benoit J.N., Womack W.A., Hernandez L., and Granger D.N. "Forward" and "backward" flow mechanisms of portal hypertension. Relative contributions in the rat model of portal vein stenosis. Gastroenterology 89 (1985) 1092-1096
6. Blanco M.D., Sastre R.L., Teijon C., Olmo R., and Teijon J.M. 5-Fluorouracil-loaded microspheres prepared by spray-drying poly(d,l-lactide) and poly(lactide-co-glicolide) polymers: characterization and drug release. J Microencapsul 22 (2005) 671-682
7. Blanco M.D., Sastre R.L., Teijon C., Olmo R., and Teijon J.M. Degradation behaviour of microspheres prepared by spray-drying poly (d,l-lactide)- and poly (d,l-lactide-co-glycolide) polymers. Int J Pharm 326 (2006) 139-147
8. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72 (1976) 248-254
9. Castañeda B., Dubernardi-Venon W., and Bandi J.C. The role of portal pressure in the severity of bleeding in portal hypertensive rats. Hepatology 31 (2000) 581-586
10. Chojkier M., and Groszmann R.J. Measurement of portal systemic shunting in the rat by using γ-labeled microspheres. Am J Physiol 240 (1981) G371-G375
11. Corcuera M.T., Nava M.P., Angulo A., Aller M.A., Gómez F., Casado I., et al. Splanchnic remodeling secondary to experimental prehepatic portal hypertension. Ann Med Int 22 (2005) 317-322
12. Craps L.P. Ketotifen: current views on its mechanism of action and their therapeutic implication. Respiration 45 (1984) 411-421
13. Davies M.G., and Hagen P.-O. The vascular endothelium. A new horizon. Ann Surg 218 (1993) 593-609
14. Davies P.F., and Tripathi S.C. Mechanical stress mechanisms and the cell: an endothelial paradigm. Circ Res 72 (1993) 239-245
15. Diez-Arias J.A., Aller M.A., Palma M.D., Arias J.L., Muñiz E., Sánchez M., et al. Increased duodenal mucosa infiltration by mast cells in rat with portal hypertension. Dig Surg 18 (2001) 34-40
16. Gaboury J.P., Nio X.-F., and Kubes P. Nitric oxide inhibits numerous features of mast cell-induced inflammation. Circulation 93 (1996) 318-326
17. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M.M., and Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Ann Rev Immunol 23 (2005) 749-786
18. García-Cardeña G., Comander J., Anderson K.R., Blackman B.R., and Gimbrone Jr. M.A. Biochemical activation of vascular endothelium as a determinant of its functional phenotype. Proc Natl Acad Sci USA 98 (2001) 4478-4485
19. Garcia-Tsao G., Albillos A., Barden G.E., and West A.B. Bacterial translocation in acute and chronic portal hypertension. Hepatology 17 (1993) 1081-1085
20. Gautreaux M.D., Deitch E.A., and Berg R.D. Bacterial Translocation from the gastrointestinal tract to various segments of the mesenteric lymph node complex. Infect Immun 62 (1994) 2132-2134
21. Geraghty J.G., Angerson W.J., and Caster D.C. Portal venous pressure and portasystemic shunting in experimental portal hypertension. Am J Physiol 257 (1987) G52-G57
22. Giunchedi P., and Coste U. Spray-drying as a preparation method of microparticulate drug delivery systems: an overview. STP Pharm Sci 5 (1995) 276-283
23. Grant S.M., Goa K.L., Fitton A., and Sorkin E.M. Ketotifen. A review of its pharmacodynamic and pharmacocicnetic properties, and therapeutic use in asthma and allergic disorders. Drugs 40 (1990) 412-448
24. Groszmann R.J., and Abraldes J.G. Portal hypertension: from bedside to bench. J Clin Gastroenterol 39 (2005) S125-S130
25. Guerrero S, Muñiz E, Teijon C, Olmo R, Teijon JM, Blanco MD. Ketotifen-loaded microspheres by spray-drying poly(d,l-lactide) and poly(d,l-lactide-co-glycolide) polymers: characterization and in vivo evaluation. J Pharm Sci 2007; Nov 19 [Epub ahead of print].
26. Hashimoto Y., Arai I., Tanaka M., and Nakaike S. Prostagladin D2 inhibits IgE-mediated scratching by suppressing Histamine release from mast cells. J Pharmacol Sci 98 (2005) 90-93
27. Hashimoto T., Omata H., and Honda K. Lysophosphatidic acid (LPA) induces plasma exudation and Histamine release in mice via LPA receptors. J Pharmacol Sci 100 (2006) 82-87
28. He S.H. Key role of mast cells and their major secretory products in inflammatory bowel disease. World J Gastroenterol 10 (2004) 309-318
29. Huntley J.F., Mackellar A., Newlands G.F.J., Irvine J., and Miller H.R.P. Mapping of the rat mast cell proteinases RMCP I and II by enzyme-linked immunosorbent assay and paired immunofluorescence. APMIS 98 (1990) 933-944
30. Juanola C., Giralt M., Jiménez M., Mourelle M., and Vergara P. Mucosal mast cells are involved in CCK disruption of MMC in the rat intestine. Am J Physiol 275 (1998) G63-G67
31. Kalia N., Bardhan K.D., Reed M.W., Jacob S., and Brown N.J. Mast cell stabilization prevents ethanol-induced rat gastric mucosal injury: mechanisms of protection. J Gastroenterol Hepatol 15 (2000) 133-141
32. Kalia N., Brown N.J., Wood R.F., and Pockley A.G. Ketotifen abrogates local and systemic consequences of rat intestinal ischemia-reperfusion injury. J Gastroenterol Hepatol 20 (2005) 1032-1037
33. Kanwar S., and Kubes P. Mast cells contribute to ischemia-reperfusion-induced granulocyte infiltration and intestinal dysfunction. Am J Physiol 267 (1994) G316-G321
34. Kubes P., Kanwar S., Niu X.-F., and Gaboury J.P. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J 7 (1993) 1293-1299
35. Lau H.Y.A., and Pearce F.L. Effects of antihistamines on isolated rat peritoneal mast cells and on model membrane systems. Agents Actions 29 (1990) 151-161
36. Lebrec D., and Moreau R. Pathogenesis of portal hypertension. Eur J Gastroenterol Hepatol 13 (2001) 309-311
37. Lee F.Y., Colombato L.A., Albillos A., and Groszmann R.J. Administration of Nw-Nitro-l-arginine ameliorates portal systemic shunting in portal-hypertensive rats. Gastroenterology 105 (1993) 1461-1470
38. Lin H.C., Yang M.C.-M., Hou M.-C., Li S.-M., Huang Y.-T., Yu P.-C., et al. Effects of long-term administration of Octreotide in portal vein-stenosed rats. Hepatology 23 (1996) 537-543
39. Lundequist A., Tchougounova E., Abrink M., and Pejler G. Cooperation between mast cell carboxypeptidase A and the chymase mouse mast cell protease 4 in the formation and degradation of angiotensin II. J Biol Chem 279 (2004) 32339-32344
40. Lutzelschwab C., Pejler G., Aveskogh M., and Hellman L. Secretory granule proteases in rat mast cells cloning of 10 different serine proteases and a carboxypeptidase A from various rat mast cell populations. J Exp Med 185 (1997) 13-29
41. Martin U., and Roemer D. Ketotifen, a new type of antianaphylactic agent. Allergol Immunopathol (1977) 5
42. Maurer M., Theoharides T., Granstein R.D., Bischoff S.C., Bienenstock J., Henz B., et al. What is the physiological function of mast cells?. Exp Dermatol 12 (2003) 886-910
43. Miller H.R., and Pemberton A.D. Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology 105 (2002) 375-390
44. Misra V., Misra S.P., Dwivedi M., and Gupta S.C. Histomorphometric study of portal hypertensive enteropathy. Am J Clin Pathol 108 (1997) 652-657
45. Monterde G., Rodriguez-Fabian G., Vara E., Lopez L., Arias J.L., Aller M.A., et al. Increased plasma levels of corticosterone and prolactin and decreased T3 and T4 levels in short-term prehepatic portal hypertension in rats. Dig Dis Sci 45 (2000) 1865-1871
46. Palgan K., Kolakowska J., Zbikowska-Gotz M., and Dziedziczko I. The role of mast cells in inflammatory reactions. Pneumonol Alergol Pol 68 (2000) 603-609
47. Prieto I., Aller M.A., Santamaria L., Nava M.P., Madero R., Perez-Robledo J.P., et al. Prehepatic portal hypertension produces increased mast cell density in the small bowel and in mesenteric lymph nodes in the rat. J Gastroenterol Hepatol 20 (2005) 1025-1031
48. Ruh J., Vogel F., and Schmidt E. In vivo assessment of villous microcirculation in the rat small intestine in indomethacine-induced inflammation: role of mast cell stabilizer Ketotifen. Acta Physiol Scand 170 (2000) 127-143
49. Scudamore C.L., Pennington A.M., Thornton E., McMillan L., Newlands G.F., and Miller H.R.l. Basal secretion and anaphylactic release of rat mast cell protease-II (RMCP-II) from ex vivo perfused rat jejunum: translocation of RMCP-II into the gut lumen and its relation to mucosal histology. Gut 37 (1995) 235-241
50. Sikuler E., Kravetz D., and Groszmann R.J. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol 248 (1985) G618-G625
51. Tkaczyk C., Villa I., Peronet R., David B., and Mecheri S. FcepsilonRI-mediated antigen endocytosis turns interferon-gamma-treated mouse mast cells from inefficient into potent antigen-presenting cells. Immunology 97 (1999) 333-340
52. Touyz R.M. Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II - editorial review. Curr Opin Nephrol Hypertens 14 (2005) 125-131
53. Vega de Ceniga M., Valdes F., Aller M.A., Nava M.P., Chivato T., and Arias J. Budesonide ameliorates early portal hypertension in the rat: possible antiexudative splanchnic action. Inflammopharmacology 11 (2003) 211-222
54. Vliagoftis H., and Befus A.D. Mast cells at mucosal frontiers. Curr Mol Med 5 (2005) 573-589
55. Wang H.W., Tedla N., Lloyd A.R., Wakefield D., and McNeil P.H. Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J Clin Invest 102 (1998) 1617-1626
56. Yagi N., Taniuchi Y., Hamada K., Sudo J., and Sekikawa H. Pharmacokinetics of ketotifen fumarate alter intravenous, intranasal, oral and rectal administration in rabbits. Biol Pharm Bull 25 (2002) 1614-1618